miRNAs affecting fibrinogen synthesis
miRNA ID . | Fold change in fibrinogen production (log2)* . | Relative change in fibrinogen production, percentage† . | P‡ . | Expression in liver and HuH7 . |
---|---|---|---|---|
Down-regulators | ||||
hsa-miR-29a | −1.46 | −63.6 | .0132 | E |
hsa-miR-218 | −1.23 | −57.3 | .0144 | E |
hsa-miR-409-3p | −0.88 | −45.5 | .0448 | E§ |
hsa-miR-200c | −0.86 | −44.8 | .0146 | E |
hsa-miR-29c | −0.83 | −43.7 | .0434 | E |
hsa-miR-425-5p | −0.82 | −43.2 | .0114 | E |
hsa-miR-195 | −0.80 | −42.7 | .0058 | E |
hsa-miR-199b | −0.79 | −42.2 | .0428 | E |
hsa-miR-31 | −0.77 | −41.5 | .0208 | E |
hsa-miR-429 | −0.77 | −41.3 | .0388 | E |
hsa-miR-197 | −0.67 | −37.0 | .0180 | E |
hsa-miR-28 | −0.63 | −35.3 | .0176 | E |
hsa-miR-22 | −0.63 | −35.2 | .0086 | E |
hsa-miR-574 | −0.59 | −33.7 | .0420 | E |
hsa-miR-23b | −0.58 | −33.2 | .0028 | E |
hsa-let-7e | −0.57 | −32.7 | .0500 | E |
hsa-let-7d | −0.56 | −32.0 | .0484 | E |
hsa-miR-132 | −0.53 | −30.8 | .0048 | E |
hsa-miR-215 | −0.46 | −27.3 | .0310 | E |
hsa-miR-24 | −0.45 | −26.6 | .0264 | E |
hsa-miR-182 | −0.44 | −26.4 | .0194 | E |
hsa-miR-19b | −0.44 | −26.4 | .0346 | E |
hsa-miR-194 | −0.42 | −25.5 | .0412 | E |
Up-regulators | ||||
hsa-miR-769-5p | 0.34 | 26.2 | .0066 | E |
hsa-miR-592 | 0.44 | 35.9 | .0472 | E |
hsa-miR-126 | 0.46 | 37.6 | .0022 | E |
hsa-miR-365 | 1.20 | 129.3 | .0474 | E |
miRNA ID . | Fold change in fibrinogen production (log2)* . | Relative change in fibrinogen production, percentage† . | P‡ . | Expression in liver and HuH7 . |
---|---|---|---|---|
Down-regulators | ||||
hsa-miR-29a | −1.46 | −63.6 | .0132 | E |
hsa-miR-218 | −1.23 | −57.3 | .0144 | E |
hsa-miR-409-3p | −0.88 | −45.5 | .0448 | E§ |
hsa-miR-200c | −0.86 | −44.8 | .0146 | E |
hsa-miR-29c | −0.83 | −43.7 | .0434 | E |
hsa-miR-425-5p | −0.82 | −43.2 | .0114 | E |
hsa-miR-195 | −0.80 | −42.7 | .0058 | E |
hsa-miR-199b | −0.79 | −42.2 | .0428 | E |
hsa-miR-31 | −0.77 | −41.5 | .0208 | E |
hsa-miR-429 | −0.77 | −41.3 | .0388 | E |
hsa-miR-197 | −0.67 | −37.0 | .0180 | E |
hsa-miR-28 | −0.63 | −35.3 | .0176 | E |
hsa-miR-22 | −0.63 | −35.2 | .0086 | E |
hsa-miR-574 | −0.59 | −33.7 | .0420 | E |
hsa-miR-23b | −0.58 | −33.2 | .0028 | E |
hsa-let-7e | −0.57 | −32.7 | .0500 | E |
hsa-let-7d | −0.56 | −32.0 | .0484 | E |
hsa-miR-132 | −0.53 | −30.8 | .0048 | E |
hsa-miR-215 | −0.46 | −27.3 | .0310 | E |
hsa-miR-24 | −0.45 | −26.6 | .0264 | E |
hsa-miR-182 | −0.44 | −26.4 | .0194 | E |
hsa-miR-19b | −0.44 | −26.4 | .0346 | E |
hsa-miR-194 | −0.42 | −25.5 | .0412 | E |
Up-regulators | ||||
hsa-miR-769-5p | 0.34 | 26.2 | .0066 | E |
hsa-miR-592 | 0.44 | 35.9 | .0472 | E |
hsa-miR-126 | 0.46 | 37.6 | .0022 | E |
hsa-miR-365 | 1.20 | 129.3 | .0474 | E |
E indicates expressed.
The fold change represents the calculated ratio (Fbg/Tot Prot) in log2 compared with the reference condition transfected with a negative control miRNA precursor molecule.
This relative change represents the percentage of decrease or increase in fibrinogen production compared with the reference condition transfected with a negative control miRNA precursor molecule.
Two-sided t test, tested miRNA (n = 3) versus negative control miRNA (n = 3).
This miRNA is expressed in liver but not in HuH7 cells.